Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 21,018 Cr
P/E 32.30
Div Yield 0.21 %
Book Value βΉ205.00
52w High βΉ910.00
52w Low βΉ507.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
802.00
877.00
895.00
892.00
810.00
768.00
842.00
568.00
852.00
940.00
984.00
1,009.00
821.00
Expenses
670.00
702.00
701.00
680.00
667.00
651.00
674.00
465.00
675.00
751.00
738.00
801.00
664.00
Operating Profit
131.00
175.00
194.00
211.00
144.00
117.00
168.00
103.00
177.00
189.00
247.00
208.00
157.00
OPM %
16.00
20.00
22.00
24.00
18.00
15.00
20.00
18.00
21.00
20.00
25.00
21.00
19.00
Other Income
14.00
17.00
12.00
8.00
1.00
61.00
6.00
3.00
2.00
3.00
1.00
1.00
0.00
Depreciation
39.00
44.00
41.00
41.00
40.00
38.00
38.00
35.00
36.00
36.00
36.00
36.00
35.00
Interest
10.00
16.00
15.00
17.00
14.00
13.00
17.00
15.00
18.00
20.00
20.00
18.00
15.00
Profit before tax
97.00
132.00
150.00
162.00
91.00
127.00
119.00
56.00
126.00
137.00
192.00
156.00
107.00
Tax %
26.00
25.00
26.00
26.00
24.00
26.00
24.00
26.00
25.00
29.00
26.00
26.00
25.00
Net Profit
72.00
99.00
112.00
121.00
69.00
94.00
90.00
41.00
94.00
97.00
143.00
116.00
80.00
EPS in Rs
2.90
3.99
4.60
4.97
2.86
3.88
3.72
1.71
3.87
4.01
5.89
4.79
3.30
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
3,474.00 3,030.00 3,755.00 3,931.00 3,238.00 3,135.00 2,310.00 2,098.00 1,647.00 1,349.00 1,328.00 1,213.00
Expenses
2,750.00 2,464.00 2,951.00 3,092.00 2,589.00 2,273.00 1,816.00 1,766.00 1,353.00 1,054.00 1,058.00 1,001.00
Operating Profit
724.00 567.00 804.00 840.00 649.00 862.00 494.00 333.00 294.00 296.00 270.00 212.00
OPM %
21.00 19.00 21.00 21.00 20.00 27.00 21.00 16.00 18.00 22.00 20.00 17.00
Other Income
38.00 70.00 3.00 9.00 13.00 13.00 187.00 28.00 24.00 15.00 6.00 1.00
Interest
61.00 63.00 72.00 39.00 16.00 24.00 27.00 28.00 33.00 32.00 37.00 31.00
Depreciation
164.00 146.00 144.00 146.00 126.00 118.00 102.00 91.00 76.00 71.00 58.00 50.00
Profit before tax
536.00 427.00 591.00 664.00 520.00 733.00 553.00 242.00 208.00 207.00 181.00 132.00
Tax %
25.00 25.00 26.00 25.00 26.00 25.00 20.00 33.00 33.00 31.00 33.00 28.00
Net Profit
401.00 319.00 436.00 499.00 387.00 553.00 444.00 162.00 139.00 143.00 121.00 95.00
EPS in Rs
16.17 13.17 17.99 20.61 15.59 22.32 17.47 6.37 5.48 6.25 5.57 4.66
Dividend Payout %
11.00 11.00 8.00 7.00 10.00 7.00 6.00 16.00 18.00 14.00 12.00 11.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
25.00 24.00 24.00 24.00 25.00 25.00 25.00 25.00 25.00 23.00 22.00 20.00
Reserves
4,374.00 3,379.00 3,087.00 2,675.00 2,506.00 2,138.00 1,786.00 1,398.00 1,253.00 861.00 643.00 405.00
Borrowings
828.00 899.00 1,065.00 923.00 1,061.00 849.00 891.00 991.00 978.00 656.00 641.00 412.00
Other Liabilities
754.00 850.00 830.00 881.00 781.00 672.00 444.00 410.00 382.00 314.00 262.00 270.00
Total Liabilities
5,981.00 5,152.00 5,006.00 4,503.00 4,373.00 3,683.00 3,146.00 2,824.00 2,639.00 1,855.00 1,568.00 1,107.00
Fixed Assets
1,453.00 1,405.00 1,324.00 1,330.00 1,171.00 985.00 927.00 700.00 660.00 606.00 523.00 522.00
CWIP
118.00 121.00 53.00 63.00 211.00 164.00 130.00 333.00 286.00 132.00 35.00 18.00
Investments
2,030.00 1,282.00 941.00 677.00 597.00 592.00 445.00 506.00 75.00 75.00 89.00 72.00
Other Assets
2,381.00 2,345.00 2,688.00 2,433.00 2,395.00 1,942.00 1,644.00 1,285.00 1,618.00 1,042.00 920.00 494.00
Total Assets
5,981.00 5,152.00 5,006.00 4,503.00 4,373.00 3,683.00 3,146.00 2,824.00 2,639.00 1,855.00 1,568.00 1,107.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
643.00 823.00 317.00 664.00 280.00 375.00 495.00 227.00 24.00 190.00 144.00 135.00
Cash from Investing Activity
-1,030.00 -554.00 -302.00 -97.00 -318.00 -233.00 -165.00 -243.00 -495.00 -299.00 -171.00 -130.00
Cash from Financing Activity
444.00 -340.00 26.00 -519.00 151.00 -296.00 -212.00 -17.00 529.00 36.00 86.00 25.00
Net Cash Flow
58.00 -71.00 41.00 48.00 114.00 -154.00 118.00 -33.00 58.00 -73.00 58.00 30.00
Free Cash Flow
404.00 618.00 198.00 452.00 -43.00 152.00 376.00 39.00 -251.00 7.00 44.00 33.00
CFO/OP %
110.00 161.00 59.00 100.00 65.00 65.00 124.00 94.00 26.00 84.00 71.00 78.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
131.00 156.00 159.00 127.00 136.00 118.00 99.00 122.00 154.00 127.00 122.00 58.00
Inventory Days
151.00 176.00 111.00 100.00 123.00 112.00 103.00 92.00 92.00 132.00 105.00 93.00
Days Payable
118.00 167.00 125.00 126.00 126.00 123.00 96.00 81.00 105.00 116.00 89.00 95.00
Cash Conversion Cycle
164.00 166.00 144.00 102.00 133.00 107.00 105.00 133.00 140.00 142.00 139.00 56.00
Working Capital Days
60.00 62.00 62.00 48.00 49.00 59.00 56.00 53.00 50.00 5.00 16.00 12.00
ROCE %
13.00 11.00 17.00 20.00 16.00 26.00 16.00 12.00 13.00 17.00 20.00 22.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
38.01
38.02
38.81
38.81
38.82
38.83
38.85
38.87
38.87
41.96
41.97
41.97
FIIs
17.50
15.31
13.55
14.09
13.24
15.14
15.87
19.49
20.39
19.57
18.78
21.48
DIIs
16.11
17.01
17.47
17.91
23.52
22.45
19.57
14.85
14.11
10.70
10.16
7.06
Public
28.36
29.67
30.15
29.17
24.41
23.56
25.71
26.80
26.61
27.77
29.10
29.51
No. of Shareholders
169,422
160,286
163,184
165,542
169,700
169,802
177,554
202,198
179,870
182,142
190,691
207,055
Corporate Actions
50 records
Back to all stocks